Lung cancer drug approved for phase two clinical trials

Drug maker Golden Biotechnology Corp (國鼎生技) yesterday said that its new lung cancer drug has received approval from the US Food and Drug Administration (FDA) to enter second-stage clinical trials, paving the way for the medicine to hit the world market in 2017.

Golden Biotechnology Antroquinonol Granted Orphan Drug Designation by USFDA for Treatment of Pancreatic Cancer

Golden Biotechnology Corporation, a company developing a new drug for cancer, announced that it has been granted the Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) Office of Orphan Products Development for Antroquinonol, the company's lead drug candidate. Antroquinonol received the Orphan Drug Designation in treatment of pancreatic cancer.(FDA Designation Request #14-4608).

GoldenBiotech’s new cancer drug Hocena® has been awarded the “Research and Development Innovation Award” in Taipei Biotech Awards 2014.

Having won the MOEA’s 3rd National Industrial Innovation Award in 2013, Taiwan’s leading new drug development company GoldenBiotech has again been recognized by Taiwan’s government authority to be awarded the “Research and Development Innovation Award” in Taipei Biotech Awards 2014 from Taipei City government with its research “ Hocena ®: the new NSCLC clinical drug in worldwide with multi-indications development parallely.” on 19th September 2014.

Health Ingredients Japan 2014

Exhibiting at Health Ingredients Japan 8-10 October
Booth No. 2-258, West Halls 2, "Big Sight" Exhibition Center, Tokyo
http://www.hijapan.info/eng/index.php

Vitafoods Asia 2013

Exhibiting at Vitafoods Asia 4-5 September, Booth No. FP17, AsiaWorld-Expo, Hong Kong. Please contact Charles Wang at: This email address is being protected from spambots. You need JavaScript enabled to view it. for details.

http://www.vitafoodsasia.com/ 

 

BioTaiwan 2013

Exhibiting at Bio Taiwan 18-21 July, Booth No. K1001, TWTC Nangang Exhibition Center, Taipei, Taiwan. Please contact Charles Wang This email address is being protected from spambots. You need JavaScript enabled to view it. for details.

http://www.bioclub.com.tw/en/

 

IFIA (International Food Ingredients & Additives Exhibition and Conference) Japan 2013

We will be exhibiting at IFIA Japan 15-17 May, booth #EF1032, McCormik Place. Please contact Charles Wang This email address is being protected from spambots. You need JavaScript enabled to view it. for details.

logoantro2

AntroQ Biotechnology Sdn Bhd(105091-W)
Unit 13A, Level 2,
IOI Boulevard, Jalan Kenari 4, Bandar Puchong Jaya,
47100, Selangor Darul Ehsan, Malaysia.


(Tel) 603-8074 7008
(Fax) 603-8074 9008
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Latest News

bot001

Golden Biotechnology Corporation, a company developing a new drug for cancer, announced that it has been granted the Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) Office of Orphan Products Development for Antroquinonol, the company's lead drug candidate

Technology

bot002

Golden Biotech has established a fermentation databank. We have signed an exclusive deal with major academic institutions in Taiwan to obtain fungus strains. Currently, 4000 fungus strains have been screened and stored in our databank. Screening is done in parallel with testing and data collection of all the fungus strains.....

Facebook Like Box